VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2022 | Improving immunotherapy for the treatment of patients with ovarian cancer

Benoit You, MD, PhD, Centre Hospitalier Lyon-Sud, Saint-Genis-Laval, France, discusses how immunotherapy (IO) could be improved for the treatment of ovarian cancer. IO has thus far not been so successful in patients with ovarian cancer. A better selection process of which patients will benefit could improve IO success rates and utilizing the CA-125 ELIMination rate constant K (KELIM). This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter